Alan Glicklich, Chief Medical Officer at CHINOOK THERAPEUTICS, INC. (KDNY), sold 20,000 shares at $16.35 ($327K) on 2021-06-16, disclosed to the SEC on 2021-06-17.
Open-market sale of $327k KDNY by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.